Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.8303
-0.0310 (-3.60%)
At close: May 15, 2026, 4:00 PM EDT
0.8613
+0.0310 (3.73%)
After-hours: May 15, 2026, 7:59 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $8.65 million as of May 15, 2026. Its market cap has increased by 31.05% in one year.
Market Cap
8.65M
Enterprise Value
-9.40M
1-Year Change
31.05%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $8.65M, a decrease of -23.46%. That is a compound annual growth rate of -3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 8.80M | 120.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
| Mar 29, 2018 | 11.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 10.03M |
| Imunon | 10.00M |
| Bolt Biotherapeutics | 9.61M |
| PMGC Holdings | 9.17M |
| CDT Equity | 9.04M |
| Curanex Pharmaceuticals | 8.94M |
| Creative Medical Technology Holdings | 8.28M |
| Liminatus Pharma | 8.26M |